Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-7217
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study ; volume:190 ; number:3 ; day:21 ; month:9 ; year:2021 ; pages:415-424 ; date:12.2021
Breast cancer research and treatment ; 190, Heft 3 (21.9.2021), 415-424, 12.2021

Urheber
Cazzaniga, M. E.
Vallini, I.
Montagna, E.
Amoroso, D.
Berardi, R.
Butera, A.
Cagossi, K.
Cavanna, L.
Ciccarese, M.
Cinieri, S.
Cretella, E.
Conciliis, E. De
Febbraro, A.
Ferraù, F.
Ferzi, A.
Baldelli, A.
Fontana, A.
Gambaro, A. R.
Garrone, O.
Gebbia, V.
Generali, D.
Gianni, L.
Giovanardi, F.
Grassadonia, A.
Leonardi, V.
Marchetti, P.
Sarti, S.
Musolino, A.
Nicolini, M.
Putzu, C.
Riccardi, F.
Santini, D.
Saracchini, S.
Sarobba, M. G.
Schintu, M. G.
Scognamiglio, G.
Spadaro, P.
Taverniti, C.
Toniolo, D.
Tralongo, P.
Turletti, A.
Valenza, R.
Valerio, M. R.
Vici, P.
Mauro, P. Di
Cogliati, V.
Capici, S.
Clivio, L.
Torri, V.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s10549-021-06375-5
URN
urn:nbn:de:101:1-2022010918451269958577
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:33 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Cazzaniga, M. E.
  • Vallini, I.
  • Montagna, E.
  • Amoroso, D.
  • Berardi, R.
  • Butera, A.
  • Cagossi, K.
  • Cavanna, L.
  • Ciccarese, M.
  • Cinieri, S.
  • Cretella, E.
  • Conciliis, E. De
  • Febbraro, A.
  • Ferraù, F.
  • Ferzi, A.
  • Baldelli, A.
  • Fontana, A.
  • Gambaro, A. R.
  • Garrone, O.
  • Gebbia, V.
  • Generali, D.
  • Gianni, L.
  • Giovanardi, F.
  • Grassadonia, A.
  • Leonardi, V.
  • Marchetti, P.
  • Sarti, S.
  • Musolino, A.
  • Nicolini, M.
  • Putzu, C.
  • Riccardi, F.
  • Santini, D.
  • Saracchini, S.
  • Sarobba, M. G.
  • Schintu, M. G.
  • Scognamiglio, G.
  • Spadaro, P.
  • Taverniti, C.
  • Toniolo, D.
  • Tralongo, P.
  • Turletti, A.
  • Valenza, R.
  • Valerio, M. R.
  • Vici, P.
  • Mauro, P. Di
  • Cogliati, V.
  • Capici, S.
  • Clivio, L.
  • Torri, V.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Metastatic Triple-Negative Breast Cancer

Metastatic Triple-Negative Breast Cancer

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice

Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51

Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study

Updated Austrian treatment algorithm for metastatic triple-negative breast cancer

Updated Austrian treatment algorithm for metastatic triple-negative breast cancer

Metastatic and triple-negative breast cancer: challenges and treatment options

Metastatic and triple-negative breast cancer: challenges and treatment options

Analysis of CXCL11 expression in high-grade serous ovarian cancer (HGSOC) and triple-negative breast cancer (TNBC)

Analysis of CXCL11 expression in high-grade serous ovarian cancer (HGSOC) and triple-negative breast cancer (TNBC)

Practical consensus recommendations on management of triple-negative metastatic breast cancer

Practical consensus recommendations on management of triple-negative metastatic breast cancer

Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)

Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer

SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer

Verbundene Objekte